![Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories | Open Biology Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories | Open Biology](https://royalsocietypublishing.org/cms/asset/281b76d7-73b0-4471-831d-db39046cfd57/rsob200247f02.gif)
Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories | Open Biology
![A mouse model of lung cancer induced via intranasal injection for anticancer drug screening and evaluation of pathology - Tanaka - 2023 - FEBS Open Bio - Wiley Online Library A mouse model of lung cancer induced via intranasal injection for anticancer drug screening and evaluation of pathology - Tanaka - 2023 - FEBS Open Bio - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/dc6f4897-8740-48cf-b471-d8da54192c58/feb413486-fig-0003-m.jpg)
A mouse model of lung cancer induced via intranasal injection for anticancer drug screening and evaluation of pathology - Tanaka - 2023 - FEBS Open Bio - Wiley Online Library
![Frontiers | Preclinical Model of Stereotactic Ablative Lung Irradiation Using Arc Delivery in the Mouse: Is Fractionation Worthwhile? Frontiers | Preclinical Model of Stereotactic Ablative Lung Irradiation Using Arc Delivery in the Mouse: Is Fractionation Worthwhile?](https://www.frontiersin.org/files/Articles/794324/fmed-08-794324-HTML/image_m/fmed-08-794324-g001.jpg)
Frontiers | Preclinical Model of Stereotactic Ablative Lung Irradiation Using Arc Delivery in the Mouse: Is Fractionation Worthwhile?
![Development of syngeneic murine cell lines for use in immunocompetent orthotopic lung cancer models | Cancer Cell International | Full Text Development of syngeneic murine cell lines for use in immunocompetent orthotopic lung cancer models | Cancer Cell International | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12935-020-01503-5/MediaObjects/12935_2020_1503_Fig3_HTML.png)
Development of syngeneic murine cell lines for use in immunocompetent orthotopic lung cancer models | Cancer Cell International | Full Text
![Improvement of orthotopic lung cancer mouse model via thoracotomy and orotracheal intubation enabling in vivo imaging studies - Geun Ho Im, Moon-Sun Jang, Julius Juhyun Chung, Kyoung-Nam Kim, Jae-Hun Kim, Sun I Improvement of orthotopic lung cancer mouse model via thoracotomy and orotracheal intubation enabling in vivo imaging studies - Geun Ho Im, Moon-Sun Jang, Julius Juhyun Chung, Kyoung-Nam Kim, Jae-Hun Kim, Sun I](https://journals.sagepub.com/cms/10.1177/0023677213512821/asset/images/large/10.1177_0023677213512821-fig2.jpeg)
Improvement of orthotopic lung cancer mouse model via thoracotomy and orotracheal intubation enabling in vivo imaging studies - Geun Ho Im, Moon-Sun Jang, Julius Juhyun Chung, Kyoung-Nam Kim, Jae-Hun Kim, Sun I
![Development of syngeneic murine cell lines for use in immunocompetent orthotopic lung cancer models | Cancer Cell International | Full Text Development of syngeneic murine cell lines for use in immunocompetent orthotopic lung cancer models | Cancer Cell International | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12935-020-01503-5/MediaObjects/12935_2020_1503_Fig2_HTML.png)
Development of syngeneic murine cell lines for use in immunocompetent orthotopic lung cancer models | Cancer Cell International | Full Text
![JCI - Ubiquitination of tumor suppressor PML regulates prometastatic and immunosuppressive tumor microenvironment JCI - Ubiquitination of tumor suppressor PML regulates prometastatic and immunosuppressive tumor microenvironment](https://dm5migu4zj3pb.cloudfront.net/manuscripts/89000/89957/medium/JCI89957.f7.jpg)
JCI - Ubiquitination of tumor suppressor PML regulates prometastatic and immunosuppressive tumor microenvironment
![Changes and sex- and age-related differences in the expression of drug metabolizing enzymes in a KRAS-mutant mouse model of lung cancer [PeerJ] Changes and sex- and age-related differences in the expression of drug metabolizing enzymes in a KRAS-mutant mouse model of lung cancer [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2020/10182/1/fig-1-full.png)
Changes and sex- and age-related differences in the expression of drug metabolizing enzymes in a KRAS-mutant mouse model of lung cancer [PeerJ]
![Animal Model of Human Cancer: Malignant Lymphoma/Colon Cancer/Lung Cancer/Liver Cancer/Brain Tumors/Skin Cancer | SpringerLink Animal Model of Human Cancer: Malignant Lymphoma/Colon Cancer/Lung Cancer/Liver Cancer/Brain Tumors/Skin Cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/chp%3A10.1007%2F978-981-19-1282-5_13-1/MediaObjects/528623_0_En_13-1_Fig1_HTML.png)
Animal Model of Human Cancer: Malignant Lymphoma/Colon Cancer/Lung Cancer/Liver Cancer/Brain Tumors/Skin Cancer | SpringerLink
![Cancers | Free Full-Text | Lung Adenocarcinoma Mouse Models Based on Orthotopic Transplantation of Syngeneic Tumor-Initiating Cells Expressing EpCAM, SCA-1, and Ly6d Cancers | Free Full-Text | Lung Adenocarcinoma Mouse Models Based on Orthotopic Transplantation of Syngeneic Tumor-Initiating Cells Expressing EpCAM, SCA-1, and Ly6d](https://www.mdpi.com/cancers/cancers-12-03805/article_deploy/html/images/cancers-12-03805-g002.png)
Cancers | Free Full-Text | Lung Adenocarcinoma Mouse Models Based on Orthotopic Transplantation of Syngeneic Tumor-Initiating Cells Expressing EpCAM, SCA-1, and Ly6d
![Cancers | Free Full-Text | Lung Adenocarcinoma Mouse Models Based on Orthotopic Transplantation of Syngeneic Tumor-Initiating Cells Expressing EpCAM, SCA-1, and Ly6d Cancers | Free Full-Text | Lung Adenocarcinoma Mouse Models Based on Orthotopic Transplantation of Syngeneic Tumor-Initiating Cells Expressing EpCAM, SCA-1, and Ly6d](https://www.mdpi.com/cancers/cancers-12-03805/article_deploy/html/images/cancers-12-03805-g006.png)
Cancers | Free Full-Text | Lung Adenocarcinoma Mouse Models Based on Orthotopic Transplantation of Syngeneic Tumor-Initiating Cells Expressing EpCAM, SCA-1, and Ly6d
Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model | PLOS ONE
![Development of syngeneic murine cell lines for use in immunocompetent orthotopic lung cancer models | Cancer Cell International | Full Text Development of syngeneic murine cell lines for use in immunocompetent orthotopic lung cancer models | Cancer Cell International | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12935-020-01503-5/MediaObjects/12935_2020_1503_Fig7_HTML.png)
Development of syngeneic murine cell lines for use in immunocompetent orthotopic lung cancer models | Cancer Cell International | Full Text
![An optimized protocol for the generation and monitoring of conditional orthotopic lung cancer in the KP mouse model using an adeno-associated virus vector compatible with biosafety level 1 | Cancer Immunology, Immunotherapy An optimized protocol for the generation and monitoring of conditional orthotopic lung cancer in the KP mouse model using an adeno-associated virus vector compatible with biosafety level 1 | Cancer Immunology, Immunotherapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00262-023-03542-z/MediaObjects/262_2023_3542_Fig3_HTML.png)
An optimized protocol for the generation and monitoring of conditional orthotopic lung cancer in the KP mouse model using an adeno-associated virus vector compatible with biosafety level 1 | Cancer Immunology, Immunotherapy
![Preclinical Evaluation of 99mTc-MAG3-5-Fab Targeting TREM2 in Lung Cancer Mouse Models: A Comparison with 99mTc-MAG3-5-F(ab′)2 | Molecular Pharmaceutics Preclinical Evaluation of 99mTc-MAG3-5-Fab Targeting TREM2 in Lung Cancer Mouse Models: A Comparison with 99mTc-MAG3-5-F(ab′)2 | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.3c00870/asset/images/medium/mp3c00870_0008.gif)
Preclinical Evaluation of 99mTc-MAG3-5-Fab Targeting TREM2 in Lung Cancer Mouse Models: A Comparison with 99mTc-MAG3-5-F(ab′)2 | Molecular Pharmaceutics
![A mouse model for the study of anti-tumor T cell responses in Kras-driven lung adenocarcinoma - ScienceDirect A mouse model for the study of anti-tumor T cell responses in Kras-driven lung adenocarcinoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2667237521001351-fx1.jpg)
A mouse model for the study of anti-tumor T cell responses in Kras-driven lung adenocarcinoma - ScienceDirect
![A mouse model of lung cancer induced via intranasal injection for anticancer drug screening and evaluation of pathology - Tanaka - 2023 - FEBS Open Bio - Wiley Online Library A mouse model of lung cancer induced via intranasal injection for anticancer drug screening and evaluation of pathology - Tanaka - 2023 - FEBS Open Bio - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/f3c5233e-6052-43e3-aca3-27d07a661eef/feb413486-fig-0004-m.jpg)